102 related articles for article (PubMed ID: 20175962)
21. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.
Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Otsuka Y; Yamaguchi M; Ohnishi H; Ohtaki S; Noshiro S; Ookawa S; Mikami T; Mikuni N; Honmou O
J Neurosurg Sci; 2018 Jun; 62(3):239-244. PubMed ID: 28079349
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?
Oehring RD; Miletic M; Valter MM; Pietsch T; Neumann J; Fimmers R; Schlegel U
J Neurooncol; 1999; 45(2):117-25. PubMed ID: 10778727
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.
Higgins RJ; Dickinson PJ; LeCouteur RA; Bollen AW; Wang H; Wang H; Corely LJ; Moore LM; Zang W; Fuller GN
J Neurooncol; 2010 May; 98(1):49-55. PubMed ID: 19967449
[TBL] [Abstract][Full Text] [Related]
25. The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas.
Wacker MR; Hoshino T; Ahn DK; Davis RL; Prados MD
J Neurooncol; 1994; 19(2):113-22. PubMed ID: 7964986
[TBL] [Abstract][Full Text] [Related]
26. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
27. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
[TBL] [Abstract][Full Text] [Related]
28. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
[TBL] [Abstract][Full Text] [Related]
29. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
Ohgaki H; Kleihues P
J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
31. Ezrin expression in tissue microarray of primary and recurrent gliomas.
Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
[TBL] [Abstract][Full Text] [Related]
32. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
33. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in
Felsberg J; Hentschel B; Kaulich K; Gramatzki D; Zacher A; Malzkorn B; Kamp M; Sabel M; Simon M; Westphal M; Schackert G; Tonn JC; Pietsch T; von Deimling A; Loeffler M; Reifenberger G; Weller M;
Clin Cancer Res; 2017 Nov; 23(22):6846-6855. PubMed ID: 28855349
[No Abstract] [Full Text] [Related]
34. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F
Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156
[TBL] [Abstract][Full Text] [Related]
35. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
Erdamar S; Bagci P; Oz B; Dirican A
J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
[TBL] [Abstract][Full Text] [Related]
36. Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals.
Li YX; Aibaidula A; Shi Z; Chen H; Li KK; Chung NY; Yang RR; Chan DT; Poon WS; Lee KLR; Mao Y; Wu J; Chan AK; Zhou L; Ng HK
J Neurooncol; 2018 Sep; 139(2):307-322. PubMed ID: 29761369
[TBL] [Abstract][Full Text] [Related]
37. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
[TBL] [Abstract][Full Text] [Related]
38. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
[TBL] [Abstract][Full Text] [Related]
39. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of vessels with smooth muscle layer in astrocytic tumors: correlation with histological grade and prognostic significance.
Sato S; Sato Y; Hatakeyama K; Marutsuka K; Yamashita A; Takeshima H; Asada Y
Histol Histopathol; 2011 Apr; 26(4):497-504. PubMed ID: 21360443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]